Fig. 2From: Establishment and application of a CRISPR-Cas12a-based RPA-LFS and fluorescence for the detection of Trichomonas vaginalisSpecificity of the RPA-CRISPR-Cas12a detection platform. a Agarose gel electrophoresis of the genomes of Trichomonas vaginalis, eight pathogens (C. albicans, M. mycoplasma, N. gonorrhoeae, E. coli, C. parvum, G. lambila and T. gondii) and the human genome after RPA amplification. b Specificity of the RPA-CRISPR-Cas12a platform for the detection of T. vaginalis by fluorescence. c The fluorescence multiplicity change (FC) of eight pathogens, the human genome and T. vaginalis, FC = (F (PC) − B (PC))/(F (NC) − B (NC)). d Specificity of the RPA-CRISPR-Cas12a platform for the detection of T. vaginalis by the LFS sensorBack to article page